Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Recruiting · NCT04254263 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer | Locally Advanced Breast Cancer | Recruiting | Phase 3 | 2025-09-11 | NCT04254263 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University | Shanghai | China | 16 |